Cefotaxime Sodium Powder for Solution Shortage: Current Status and Manufacturer Updates
Cefotaxime Sodium Powder for Solution is currently in shortage due to increased demand, with Hikma Pharmaceuticals reporting total unavailability across all presentations.
What’s in Shortage
Drug Name: Cefotaxime Sodium Powder, for Solution (Brand Name: CEFOTAXIME) Dosage Form: Powder, For Solution Therapeutic Category: Anti-Infective, Pediatric Current Status: Current Shortage
Which Manufacturers Are Affected
Hikma Pharmaceuticals USA, Inc.
- Status: Unavailable
- Notes: Shortage duration is unknown at this time.
- Affected Presentations:
- Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)
- Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)
- Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)
- Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)
- Contact Information: 800-631-2174
Why There’s a Shortage
The FDA reports that the shortage of Cefotaxime Sodium is due to a demand increase for the drug.
What Patients Should Do
If you or your child are prescribed this medication, please take the following steps:
- Consult Your Healthcare Provider: Discuss the shortage with your doctor to determine the best course of action for treatment.
- Talk to Your Pharmacist: Pharmacists may have information on local stock or potential alternatives.
- Contact the Manufacturer: You can reach Hikma Pharmaceuticals at 800-631-2174 for the most recent updates on availability.
Disclaimer: Patients should always consult their healthcare provider for medical advice and treatment options. Do not change or stop medication without professional guidance.
Source
Information provided by the FDA Drug Shortage Database.
- Initial Posting Date: 02/17/2015
- Last Updated: 03/12/2026
Source: FDA Official Notice
Related Articles
Conivaptan Hydrochloride Injection Shortage: Current Availability and Shipping Updates
FDA · April 3, 2026
Promethazine Hydrochloride Injection Shortage: Current Status and Manufacturer Updates
FDA · March 21, 2026
Desmopressin Acetate Spray Shortage: Current Supply Updates and Manufacturer Status
FDA · March 5, 2026